PT2709604T - Canabidivarina para utilização no tratamento de dor neuropática - Google Patents

Canabidivarina para utilização no tratamento de dor neuropática

Info

Publication number
PT2709604T
PT2709604T PT127224954T PT12722495T PT2709604T PT 2709604 T PT2709604 T PT 2709604T PT 127224954 T PT127224954 T PT 127224954T PT 12722495 T PT12722495 T PT 12722495T PT 2709604 T PT2709604 T PT 2709604T
Authority
PT
Portugal
Prior art keywords
canabidivarin
treatment
neuropathic pain
neuropathic
pain
Prior art date
Application number
PT127224954T
Other languages
English (en)
Inventor
Guy Geoffrey
Maione Sabatino
Rossi Francesco
Stott Colin
Kikuchi Tetsuro
Original Assignee
Gw Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gw Pharma Ltd filed Critical Gw Pharma Ltd
Publication of PT2709604T publication Critical patent/PT2709604T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PT127224954T 2011-05-20 2012-05-18 Canabidivarina para utilização no tratamento de dor neuropática PT2709604T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1108506.5A GB2491118B (en) 2011-05-20 2011-05-20 Cannabinoids for use in the treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
PT2709604T true PT2709604T (pt) 2017-05-17

Family

ID=44279366

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127224954T PT2709604T (pt) 2011-05-20 2012-05-18 Canabidivarina para utilização no tratamento de dor neuropática

Country Status (22)

Country Link
US (1) US9895342B2 (pt)
EP (1) EP2709604B1 (pt)
JP (1) JP6147249B2 (pt)
KR (1) KR20140037124A (pt)
CN (1) CN103533930A (pt)
AR (1) AR086398A1 (pt)
AU (1) AU2012260611B2 (pt)
BR (1) BR112013029773A2 (pt)
CA (1) CA2833099C (pt)
CO (1) CO6811867A2 (pt)
DK (1) DK2709604T3 (pt)
EA (1) EA201391733A1 (pt)
ES (1) ES2624308T3 (pt)
GB (2) GB2524689B (pt)
IL (1) IL229474B (pt)
MX (1) MX2013013141A (pt)
PH (1) PH12013502148A1 (pt)
PT (1) PT2709604T (pt)
SG (1) SG194839A1 (pt)
TW (1) TW201249425A (pt)
WO (1) WO2012160358A1 (pt)
ZA (1) ZA201309364B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
EP3452036A4 (en) 2016-05-04 2019-11-06 Inmed Pharmaceuticals Inc. USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND ASSOCIATED BINDING WEB DISEASES
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
AU2017290107A1 (en) 2016-06-29 2019-01-17 CannScience Innovations Inc. Decarboxylated cannabis resins, uses thereof and methods of making same
CN109963595B (zh) * 2016-10-11 2023-02-03 Gbs全球生物制药公司 用于治疗神经退行性疾病的含有大麻素的复合混合物
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
WO2018236957A1 (en) * 2017-06-20 2018-12-27 Nexien Biopharma, Inc. METHOD AND COMPOSITIONS FOR TREATING REST-FREE LEG SYNDROME
CN109498606A (zh) 2017-09-15 2019-03-22 汉义生物科技（北京）有限公司 一种含有大麻二酚和/或次大麻二酚的组合物及其在治疗痛经中的应用
EP3684353A4 (en) * 2017-09-22 2021-06-23 Inmed Pharmaceuticals Inc. TOPICAL FORMULATIONS OF CANNABINOIDS AND THEIR USES FOR PAIN TREATMENT
GB2568929A (en) 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
US12458906B2 (en) 2018-01-23 2025-11-04 High Sierra Technologies, Inc. Methods of modifying a naturally occurring cannabis raw plant material, a purified cannabis product from a naturally occurring cannabis raw plant material, and a modified cannabis product from a naturally occurring cannabis raw plant material
WO2019147690A1 (en) 2018-01-23 2019-08-01 High Sierra Technologies, Inc. Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
GB201806953D0 (en) 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
US12178797B2 (en) 2019-05-03 2024-12-31 Zyus Life Sciences Inc. Formulation for pain management
US12220396B2 (en) 2019-05-03 2025-02-11 Zyus Life Sciences Inc. Formulation for pain management
KR102445087B1 (ko) * 2019-05-03 2022-09-20 자이우스 라이프 사이언시스 아이엔씨. 통증 관리용 제형
AU2021258909A1 (en) * 2020-04-24 2022-12-08 Zyus Life Sciences Inc. Cannabichromene formulation for pain management
EP4243796A4 (en) 2020-11-16 2025-01-22 Orcosa Inc. IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
CN116648241B (zh) * 2021-04-14 2025-10-10 成都百裕制药股份有限公司 氘代苯酚衍生物及其制备方法和用途
WO2025091116A1 (en) * 2023-11-02 2025-05-08 Zyus Life Sciences Inc. Treatment and prophylaxis of migraine
EP4595958A1 (en) * 2024-01-29 2025-08-06 Panaxia Pharmaceutical Industries Ltd. Cannabis compositions enriched with cbca/cbc for consistent pain relief

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1494907A (zh) 1996-03-25 2004-05-12 治疗疼痛的药物组合物
US6949582B1 (en) 1999-05-27 2005-09-27 Wallace Walter H Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment
AU2002231970B2 (en) * 2001-02-14 2007-08-16 CNX Therapeutics Limited Mucoadhesive pharmaceutical formulations
GB2381194A (en) * 2001-09-07 2003-04-30 Gw Pharmaceuticals Ltd Pharmaceutical formulations
US10004684B2 (en) * 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
US6730330B2 (en) 2001-02-14 2004-05-04 Gw Pharma Limited Pharmaceutical formulations
US7025992B2 (en) 2001-02-14 2006-04-11 Gw Pharma Limited Pharmaceutical formulations
GB2377633A (en) * 2001-05-11 2003-01-22 Gw Pharmaceuticals Ltd Pharmaceutical compositions comprising the cannabinoids THC and CBD
CH695661A5 (de) 2001-03-06 2006-07-31 Forsch Hiscia Ver Fuer Krebsfo Pharmazeutische Zusammensetzung.
EP1243262B1 (en) 2001-03-20 2006-05-31 Schwarz Pharma Ag Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
GB2381450B (en) 2001-10-31 2006-05-31 Gw Pharma Ltd Compositions for administration of natural or synthetic cannabinoids by vaporisation
PT1542657E (pt) 2002-08-14 2012-02-29 Gw Pharma Ltd Formulações líquidas canabinóides para administração pela mucosa
US6946150B2 (en) 2002-08-14 2005-09-20 Gw Pharma Limited Pharmaceutical formulation
GB2391865B (en) 2002-08-14 2005-06-01 Gw Pharma Ltd Improvements in the extraction of pharmaceutically active components from plant materials
GB2392093B (en) * 2002-08-14 2006-03-08 Gw Pharma Ltd Pharmaceutical formulations
GB0222077D0 (en) * 2002-09-23 2002-10-30 Gw Pharma Ltd Methods of preparing cannabinoids from plant material
GB2394894B (en) 2002-11-04 2005-08-31 G W Pharma Ltd New use for pharmaceutical composition
GB2414933B (en) 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
US7968594B2 (en) 2005-04-27 2011-06-28 Gw Pharma Limited Pharmaceutical compositions for the treatment of pain
EP1747786A3 (en) 2005-07-25 2007-04-25 Perdix Eurogroup S.L. Natural product in cream with anti-vitiligo therapeutic properties
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
CA2517313A1 (en) * 2005-08-26 2007-02-26 Queen's University At Kingston Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist
GB2432312A (en) 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
GB2439393B (en) 2006-06-23 2011-05-11 Gw Pharma Ltd Cannabinoids for use in the treatment of neuropathic pain
GB2448535A (en) * 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
GB2450493A (en) * 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors

Also Published As

Publication number Publication date
GB2524689A (en) 2015-09-30
CO6811867A2 (es) 2013-12-16
AR086398A1 (es) 2013-12-11
CN103533930A (zh) 2014-01-22
KR20140037124A (ko) 2014-03-26
IL229474A0 (en) 2014-01-30
SG194839A1 (en) 2013-12-30
GB201108506D0 (en) 2011-07-06
BR112013029773A2 (pt) 2017-01-17
US20140378539A9 (en) 2014-12-25
CA2833099A1 (en) 2012-11-29
NZ618246A (en) 2016-01-29
PH12013502148A1 (en) 2014-01-06
GB2491118A (en) 2012-11-28
GB2491118B (en) 2015-12-30
AU2012260611A1 (en) 2013-12-12
GB2524689B (en) 2016-01-27
EP2709604A1 (en) 2014-03-26
GB201512357D0 (en) 2015-08-19
MX2013013141A (es) 2014-02-17
JP2014513715A (ja) 2014-06-05
TW201249425A (en) 2012-12-16
WO2012160358A1 (en) 2012-11-29
CA2833099C (en) 2020-11-03
IL229474B (en) 2018-11-29
AU2012260611B2 (en) 2017-06-15
US20140107192A1 (en) 2014-04-17
JP6147249B2 (ja) 2017-06-14
DK2709604T3 (en) 2017-05-15
ES2624308T3 (es) 2017-07-13
ZA201309364B (en) 2015-04-29
US9895342B2 (en) 2018-02-20
EA201391733A1 (ru) 2014-04-30
EP2709604B1 (en) 2017-02-01

Similar Documents

Publication Publication Date Title
IL229474A0 (en) Cannabinoids for use in the treatment of neuropatich pain
BR112013011874A2 (pt) compostos e métodos para tratar dor
BR112013018469A2 (pt) dispositivos e métodos para tratamento de tecidos
PT2919796T (pt) Utilização de akkermansia para o tratamento de distúrbios metabólicos
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
HUE043171T2 (hu) Neurodegeneratív betegségek kezelésére hasznos 1-arilkarbonil-4-oxi-piperidinvegyületek
BR112013024401A2 (pt) métodos e composições para o tratamento do transtorno do déficit de atenção
BR112014005914A2 (pt) Produto para cicatrização de feridas tecidulares
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
BR112014000033A2 (pt) compostos para o tratamento de dependência química
BR112014013843A2 (pt) uso de dispositivos para o tratamento de doenças neurológicas
BRDI7106622S (pt) Configuração aplicada em remédio para alívio de dor
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
BR112013034055A2 (pt) alcaftadina para uso no tratamento de urticária
BR112014004416A2 (pt) composições e métodos para o tratamento de doenças neurodegenerativas
ZA201308541B (en) Compounds for use in treatment of mucositis
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
SMT201800604T1 (it) Composti per il trattamento di obesita' e metodi di uso degli stessi
BR112012000085A2 (pt) sistema para tratamento biológico
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
BR112014029487A2 (pt) método para o tratamento cosmético
IL227747A0 (en) Combinations comprising macitentan for the treatment of glioblastoma multiforme
BR112013028890A2 (pt) composições e métodos para o tratamento de câncer
PT2614824E (pt) Derivado de triazole para utilização no tratamento da dor neuropática e da fibromialgia
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment